Epacadostat and Pembrolizumab Before Surgery in Treating Participants With Stage II-III Esophageal or Gastroesophageal Cancer
Stopped Safety concerns
Conditions
- Esophageal Squamous Cell Carcinoma
- Esophageal Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
Interventions
- DRUG: Epacadostat
- OTHER: Laboratory Biomarker Analysis
- BIOLOGICAL: Pembrolizumab
- OTHER: Pharmacodynamic Study
Sponsor
City of Hope Medical Center
Collaborators